The global infertility market is experiencing rapid expansion, driven by rising infertility rates linked to lifestyle changes and the continuous advancement of assisted reproductive technologies (ART). According to a report by Market Research Future (MRFR), the infertility market was valued at $2.04 billion in 2024 and is expected to grow to $6.80 billion by 2034, with a compound annual growth rate (CAGR) of 12.82% over the forecast period from 2025 to 2034.
Key factors contributing to this growth include the increasing prevalence of infertility, technological advancements in ART, and the rise of minimally invasive treatments. The growing research into male infertility and efforts to reduce ART costs further drive the market’s expansion. As genetic diagnostics and treatments progress from cellular research to clinical applications, the tools and resources available to clinicians are set to expand significantly, enhancing patient outcomes.
In addition to technological developments, improved diagnostic tools, including computer-assisted imaging and combined modalities like MRI and PET scans, are expected to support quicker recovery times and more effective treatments. The report highlights data obtained through extensive primary and secondary research, providing a comprehensive analysis of market trends, challenges, and opportunities. It also examines key market parameters such as government policies, macroeconomic conditions, and competitive dynamics that could impact future growth.
The infertility market report offers valuable insights into the key segments, including diagnostic tests (for both men and women), medications (such as Clomiphene Citrate and Letrozole), ART procedures, and regional growth projections. With these advancements, the infertility market is poised for significant growth, improving the accessibility and effectiveness of treatments for couples struggling with infertility.
Related topics:
Study Highlights Increased Exposure to Teratogenic Drugs in ART Pregnancies
Mycotoxins in Follicular Fluid May Affect IVF Success, Study Reveals
AI-Powered Model Shows Promise for Detecting Cognitive Decline in Menopausal Women
